OR23-05 Human Absorption, Metabolism, Excretion, and Absolute Oral Bioavailability of (14)C-CRN00808, an Orally Bioavailable, Nonpeptide, Selective, Somatostatin Receptor 2 (sST2) Biased Agonist for the Treatment of Acromegaly

Injected depot formulations of somatostatin peptide analogs are routinely used to treat acromegaly and neuroendocrine tumors (NETs). CRN00808, a small molecule nonpeptide selective somatostatin receptor 2 (sst2) agonist, is being evaluated for efficacy and safety in patients with acromegaly. The cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Madan, Ajay, Luo, Rosa, Cook, Stephen Ferrara, Struthers, Scott, van Marle, Sjoerd, Krasner, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209640/
http://dx.doi.org/10.1210/jendso/bvaa046.696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209640/
http://dx.doi.org/10.1210/jendso/bvaa046.696

Ejemplares similares